Carbidopa; Entacapone; Levodopa Patent Expiration

Carbidopa; Entacapone; Levodopa is Used for managing the symptoms of Parkinson's disease. It was first introduced by Orion Pharma in its drug Stalevo 50 on Jun 11, 2003. Other drugs containing Carbidopa; Entacapone; Levodopa are Stalevo 150, Stalevo 100, Stalevo 125, Stalevo 200, Stalevo 75. 5 different companies have introduced drugs containing Carbidopa; Entacapone; Levodopa.


Carbidopa; Entacapone; Levodopa Patents

Given below is the list of patents protecting Carbidopa; Entacapone; Levodopa, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Stalevo 100 US6500867 Pharmaceutical composition comprising entacapone, levodopa, and carbidopa Jun 29, 2020

(Expired)

Orion Pharma
Stalevo 100 US6797732 Pharmaceutical composition comprising entracapone, levodopa, and carbidopa Jun 29, 2020

(Expired)

Orion Pharma
Stalevo 125 US6500867 Pharmaceutical composition comprising entacapone, levodopa, and carbidopa Jun 29, 2020

(Expired)

Orion Pharma
Stalevo 125 US6797732 Pharmaceutical composition comprising entracapone, levodopa, and carbidopa Jun 29, 2020

(Expired)

Orion Pharma
Stalevo 150 US6500867 Pharmaceutical composition comprising entacapone, levodopa, and carbidopa Jun 29, 2020

(Expired)

Orion Pharma
Stalevo 150 US6797732 Pharmaceutical composition comprising entracapone, levodopa, and carbidopa Jun 29, 2020

(Expired)

Orion Pharma
Stalevo 200 US6500867 Pharmaceutical composition comprising entacapone, levodopa, and carbidopa Jun 29, 2020

(Expired)

Orion Pharma
Stalevo 200 US6797732 Pharmaceutical composition comprising entracapone, levodopa, and carbidopa Jun 29, 2020

(Expired)

Orion Pharma
Stalevo 50 US6500867 Pharmaceutical composition comprising entacapone, levodopa, and carbidopa Jun 29, 2020

(Expired)

Orion Pharma
Stalevo 50 US6797732 Pharmaceutical composition comprising entracapone, levodopa, and carbidopa Jun 29, 2020

(Expired)

Orion Pharma
Stalevo 75 US6500867 Pharmaceutical composition comprising entacapone, levodopa, and carbidopa Jun 29, 2020

(Expired)

Orion Pharma
Stalevo 75 US6797732 Pharmaceutical composition comprising entracapone, levodopa, and carbidopa Jun 29, 2020

(Expired)

Orion Pharma
Stalevo 100 US5446194 Pharmacologically active catechol derivatives Oct 19, 2013

(Expired)

Orion Pharma
Stalevo 125 US5446194 Pharmacologically active catechol derivatives Oct 19, 2013

(Expired)

Orion Pharma
Stalevo 150 US5446194 Pharmacologically active catechol derivatives Oct 19, 2013

(Expired)

Orion Pharma
Stalevo 200 US5446194 Pharmacologically active catechol derivatives Oct 19, 2013

(Expired)

Orion Pharma
Stalevo 50 US5446194 Pharmacologically active catechol derivatives Oct 19, 2013

(Expired)

Orion Pharma
Stalevo 75 US5446194 Pharmacologically active catechol derivatives Oct 19, 2013

(Expired)

Orion Pharma



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Carbidopa; Entacapone; Levodopa's patents.

Given below is the list recent legal activities going on the following patents of Carbidopa; Entacapone; Levodopa.

Activity Date Patent Number
Patent litigations
Recordation of Patent Grant Mailed 28 Sep, 2004 US6797732
Patent Issue Date Used in PTA Calculation 28 Sep, 2004 US6797732
Issue Notification Mailed 09 Sep, 2004 US6797732
Receipt into Pubs 03 Sep, 2004 US6797732
Application Is Considered Ready for Issue 01 Sep, 2004 US6797732
Dispatch to FDC 01 Sep, 2004 US6797732
Issue Fee Payment Received 18 Aug, 2004 US6797732
Issue Fee Payment Verified 18 Aug, 2004 US6797732
Receipt into Pubs 17 Aug, 2004 US6797732
Receipt into Pubs 07 Jun, 2004 US6797732


Carbidopa; Entacapone; Levodopa's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Carbidopa; Entacapone; Levodopa Generic API Manufacturers

Several generic applications have been filed for Carbidopa; Entacapone; Levodopa. The first generic version for Carbidopa; Entacapone; Levodopa was by Sun Pharmaceutical Industries Ltd and was approved on May 10, 2012. And the latest generic version is by Rising Pharma Holdings Inc and was approved on Jan 25, 2022.

Given below is the list of companies who have filed for Carbidopa; Entacapone; Levodopa generic, along with the locations of their manufacturing plants worldwide.


1. NORVIUM BIOSCIENCE

Norvium Bioscience Llc has filed for 6 different strengths of generic version for Carbidopa; Entacapone; Levodopa. All of these versions come by the name CARBIDOPA, LEVODOPA AND ENTACAPONE. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.

Strength Dosage Form Availability Application Pathway TE code Launch Date
12.5MG; 200MG; 50MG

tablet Discontinued ORAL N/A Aug 13, 2020
18.75MG; 200MG; 75MG

tablet Discontinued ORAL N/A Aug 13, 2020
25MG; 200MG; 100MG

tablet Discontinued ORAL N/A Aug 13, 2020
31.25MG; 200MG; 125MG

tablet Discontinued ORAL N/A Aug 13, 2020
37.5MG; 200MG; 150MG

tablet Discontinued ORAL N/A Aug 13, 2020
50MG; 200MG; 200MG

tablet Discontinued ORAL N/A Aug 13, 2020





2. RISING

Rising Pharma Holdings Inc has filed for 6 different strengths of generic version for Carbidopa; Entacapone; Levodopa. All of these versions come by the name CARBIDOPA, LEVODOPA AND ENTACAPONE. Given below are the details of the strengths of this generic introduced by Rising.

Strength Dosage Form Availability Application Pathway TE code Launch Date
12.5MG; 200MG; 50MG

tablet Prescription ORAL AB Jan 25, 2022
18.75MG; 200MG; 75MG

tablet Prescription ORAL AB Jan 25, 2022
25MG; 200MG; 100MG

tablet Prescription ORAL AB Jan 25, 2022
31.25MG; 200MG; 125MG

tablet Prescription ORAL AB Jan 25, 2022
37.5MG; 200MG; 150MG

tablet Prescription ORAL AB Jan 25, 2022
50MG; 200MG; 200MG

tablet Prescription ORAL AB Jan 25, 2022


Manufacturing Plant Locations
New

Rising's manufacturing plants are situated in 3 countries - United States, Mexico, India. Given below are the details of these plant locations as well as the firm names of Rising as present at those locations.

Country City Firm Name
United States
Mount Morris Rising Creek Bakery LLC
Decatur Rising Pharma Holdings, Inc
Livingston Risingsun Iodine Products Corp.
Flagstaff Rising High Enterprises, LLC (DBA RisingHy)
Phoenix Rising Sun Farms Inc
Saddle Brook Rising Pharmaceuticals, Inc.
East Brunswick Rising Pharma Holding, Inc.
Fort Bragg Rising Tide Sea Vegetables
Rising Sun Rising Sun Veterinary Clinic
Mexico
Pueblo San Clemente RISING FARMS SAPI DE CV
India
Ahmedabad Rising Retina Clinic





3. SUN PHARM

Sun Pharmaceutical Industries Ltd has filed for 2 different strengths of generic version for Carbidopa; Entacapone; Levodopa. All of these versions come by the name CARBIDOPA, LEVODOPA AND ENTACAPONE. Given below are the details of the strengths of this generic introduced by Sun Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG; 200MG; 100MG

tablet Prescription ORAL AB May 10, 2012
37.5MG; 200MG; 150MG

tablet Prescription ORAL AB May 10, 2012


Manufacturing Plant Locations
New

Sun Pharm's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Sun Pharm as present at those locations.

Country City Firm Name
United States
Princeton SUN PHARMACEUTICAL INDUSTRIES INC
Billerica Sun Pharmaceutical Industries, Inc.
Lexington Sun Pharmaceutical Industries Inc
India
Ahmednagar Sun Pharmaceutical Industries Limited
Kanchipuram Sun Pharmaceutical Industries Limited- Madhuranthagam
Vadodara Sun Pharmaceutical Industries Ltd.
New Delhi Sun Pharmaceutical Industries Limited
Dadra Sun Pharmaceutical Industries Limited
Vadodara Sun Pharmaceutical Industries Ltd
Baruch Sun Pharmaceutical Industries Ltd.
Punjab Sun Pharmaceutical Industries, Inc.
Vadodara Sun Pharmaceutical Industries Limited - Karkhadi
Gurugram Sun Pharmaceutical Industries Limited (prev. Ranbaxy)
Halol Sun Pharmaceutical Industries Ltd.
Bharuch Sun Pharmaceutical Industries Ltd
Malanpur, Bhind (District) Sun Pharmaceutical Industries Limited
Mohali Sun Pharmaceutical Industries Limited





4. WOCKHARDT LTD

Wockhardt Ltd has filed for 6 different strengths of generic version for Carbidopa; Entacapone; Levodopa. All of these versions come by the name CARBIDOPA, LEVODOPA AND ENTACAPONE. Given below are the details of the strengths of this generic introduced by Wockhardt Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
12.5MG; 200MG; 50MG

tablet Discontinued ORAL N/A Nov 20, 2012
18.75MG; 200MG; 75MG

tablet Discontinued ORAL N/A Nov 20, 2012
25MG; 200MG; 100MG

tablet Discontinued ORAL N/A Nov 20, 2012
31.25MG; 200MG; 125MG

tablet Discontinued ORAL N/A Nov 20, 2012
37.5MG; 200MG; 150MG

tablet Discontinued ORAL N/A Nov 20, 2012
50MG; 200MG; 200MG

tablet Discontinued ORAL N/A Nov 20, 2012